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Summary The aim of this study was to test the hypotheses that (a) microvascular density (MVD) measured in histological sections of
resected non-small cell lung carcinomas is an index of angiogenesis and (b) the measurement of MVD in a single block is representative of
the overall MVD of the tumour. MVD was quantitated in one block per specimen of 60 lung tumours and nine normal lung tissues, and in 47
blocks taken from different regions of four tumours. Blood vessels were stained with antibody to von Willebrand Factor and MVD was
quantitated using two methods: average density throughout the section (a-MVD) and density in the most vascularized area or 'hot spot'
(h-MVD). Similar h-MVD values were found in tumours and in normal bronchus, whereas a-MVD was greater in the latter (P < 0.01). When 47
blocks from four tumours were analysed, inter-tumour variation was significant (P < 0.001) in spite of significant intra-tumour variation. The
highest MVD value was not necessarily found in the periphery of the tumour. The four tumours were ranked into either two or four tiers
according to their overall MVD. In 50 random selections of one block per tumour, the correct ranking was achieved in 68-74% of cases with
the two-tier ranking and in 6-16% of cases with the four-tier ranking (h-MVD and a-MVD values respectively). These results suggest that
elevated MVD values do not necessarily represent angiogenesis in non-small cell lung carcinomas. When only one block per tumour is
examined, the chance of obtaining an accurate estimate of the vascularity of that tumour may be lower than 68%.
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In animal models, tumour-induced angiogenesis has been shown
to be essential for tumour growth and metastasis (Folkman, 1990).
Although angiogenesis cannot be measured directly in human
tumours, recent studies have suggested that the angiogenic
potential of these tumours can be inferred by the density of the
microvasculature in tissue sections (Weidner et al, 1991; Gasparini
and Harris, 1995). In support ofthis hypothesis, many studies have
found that microvascular density (MVD), particularly when
measured in the most vascularized area or 'hot spot', is an inde-
pendent prognostic indicator in various types of tumour (Weidner
et al, 1991; Horak et al, 1992; Macchiarini et al, 1992; Folkman,
1994; Williams et al, 1994; Bochner et al, 1995; Fox et al, 1995;
Gasparini and Harris, 1995), with high MVD values associated
with poor prognosis.
However, the value of MVD as a tumour prognostic indicator
remains controversial. In contrast to the results cited above, other
studies have concluded that MVD has no predictive value
(Carnochan et al, 1991; Hall et al, 1992; Van Hoef et al, 1993;
Leedy et al, 1994; Axelsson et al, 1995; Mattem et al, 1995; Tahan
et al, 1995; Morphopoulus et al, 1996). Although studies reporting
a positive correlation outnumber those reporting no correlation
(reviewed in Gasparini and Harris, 1995), it is also of interest that
several studies found that high tumour MVD values were associ-
ated with good prognosis (Awwad et al, 1986; Delides et al, 1988;
Revesz et al 1989; Kainz et al, 1995; Zatterstrom et al, 1995).
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It has been suggested previously that these contradictory results
may be due to tumourheterogeneity (Van Hoefetal,1993; De Jong
et al, 1995). The aim of this study was to test the hypotheses that
(a) MVD estimated with a pan-endothelial antibody represents
angiogenesis in lung tumours and (b) the measurement ofMVD in
a single block is representative ofthe overall MVD ofthe tumour.
MATERIALS AND METHODS
Specimens
Formalin-fixed tissue blocks of primary non-small-cell lung
carcinoma (n = 60) and normal lung tissue (n = 9) were collected
following routine tumour resection at the Cardiothoracic Centre,
Broadgreen Hospital, Liverpool, UK. In addition, 47 blocks were
collected from three different regions of four tumours, as
explained in Results. Information related to the tumours analysed
is given in Table 1. All tumour blocks were selected on the basis of
containing ample and representative tumour areas in haematoxylin
and eosin (H&E) sections as described (Chandrachud et al, 1997).
Immunocytochemistry
Blood vessels were visualized by immunostaining 5-pm-thick
sections with rabbit anti-human von Willebrand Factor (vWF)
antibody (Dako, High Wycombe, UK) according to standard
immunocytochemistry techniques (Van Hoef et al, 1993;
Chandrachud et al, 1997; Pazouki et al, 1997). Afterdewaxing and
rehydration, sections were pretreated with protease XXIV (Sigma
Chemical, Poole, Dorset, UK) at 1 mg ml-' in phosphate-buffered
saline (PBS) for 30 min at 37°C. Normal rabbit IgG (Vector
Laboratories, Peterborough, UK) was used as a negative control.
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Table 1 Clinicopathological details of the specimens used
Single block per tumour (n = 60) Multiple blocks per tumour (n = 4)
Li L2 L3 L4
Histological cell type SCC49; Ad 11 SCC SCC SCC SCC
Age (years) Median 64, range 38-82 68 68 67 67
Gender Male 36, female 24 M M F M
Stage UICC 135, 118, Ilia 17 11 Illa II
TNM-T T1 21, T2 32, T37 Ti T2 Ti T2
TNM-N N037,Nl1 1; N2 12 Ni N2 NO Ni
Tumour maximum diameter (cm) Median 4, range 1-9 3.5 10 3.5 11
Two groups of tumours were analysed. In the first group (n = 60), one block was examined pertumour. In the second group (n = 4), 5-21 blocks were
examined for each tumour. SCC, squamous cell carcinoma; Ad, adenocarcinoma; M, male; F, female; Stage TNM-T and TNM-N as previously described
(Chandrachud et al, 1997).
Assessment of microvascular density (MVD)
MVD was assessed in one section perblock using manual counting
under light microscopy as previously described (Chandrachud et al,
1997). Briefly, a microscopic field was defined by a grid placed in
the eye-piece. Any endothelial cell or cell cluster showing vWF
staining and clearly separated from an adjacent cluster was
considered to be a single, countable microvessel. Two methods of
counting were used: highest microvascular density (h-MVD) and
average microvascular density (a-MVD). The area of highest
A
microvascular density or 'hot spot' was located by scanning the
section at 1OOx magnification. Three fields were counted in this
area at 200x magnification and the highest value was taken as
h-MVD (Weidner et al, 1991). a-MVD was determined using the
same grid and magnification (200x) as for h-MVD but calculating
the mean ofthe vascular counts obtained in 15 random fields across




Figure 1 Vessels stained with vWF antibody in normal bronchial tissue and lung tumour. Histological sections of representative specimens of normal lung and
lung tumour were stained with antibody to vWF. Micrographs taken from different areas of the same section show heterogeneity in the distribution of the vessels
in both normal bronchial tissue (A and B) and lung squamous cell carcinoma (C and D). Note also the similar number of vessels in both specimens. Arrows
indicate all the vessels stained in low-vascularity areas (B and D) and a few examples of vessels stained in high vascularity areas (A and B). Bar = 50gm
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Table 2 Microvascular density in lung tumours and normal bronchus
Tissue (n) h-MVD a-MVD
Meana Range Meana Range
Tumours (60) 145 52-334 69 21-201
Bronchus (9) 147 113-219 112 89-155
P-value 0.93 0.005
Tissue sections were immunostained for vWF. Vascularity, quantitated by the
highest (h-MVD) and the average (a-MVD) microvascular density, is
expressed as the mean and range (vessels mm-2) of the number of
specimens shown (n). The unpaired t-test was used to assess differences
between tumours and normal bronchus (Pvalues shown). aDetransformed
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Figure 2 Microvascular density in lung carcinomas. Multiple paraffin blocks
(n = 47) were obtained from four lung tumours (Li, L2, L3, L4). Between one
and nine blocks were examined from each of three regions: the tumour
periphery (1), the centre of the tumour (3) and an area between regions 1
and 3 (2). One section from each block was immunostained with anti-vWF
antibody and quantitated for h-MVD (-) and a-MVD (0). The values obtained
(vessels mm-2) are plotted against tumour number (L1-L4) and region (1-3)
The field measured at 200x magnification normally represented
an area of 0.476 mm2 (Chandrachud et al, 1997; Pazouki et al,
1997). However, for normal bronchial tissue, the areas to be scored
(i.e. the stroma adjacent to the bronchial epithelium) were some-
times smaller than the counting grid; in these cases, the area
counted was estimated with a Videoplan 2.2 image analysis system
(Kontron Elektronik). In tumour sections, any necrotic or sclerotic
area present was excluded from the measurement of MVD. In all
cases MVD was expressed as the number ofvessels mm-2.
Statistical analyses
Statistical analyses were performed using SPSS for Windows
release 6.1.3 and GLIM statistical software. A square-root trans-
formation of the MVD data was required to produce an adequate
normal distribution. Spearman's rank correlation was used to
compare the rank order of tissues quantitated for a-MVD and h-
MVD. Two-tailed t-tests were used to compare MVD in tumours
and in normal tissues. Tumour heterogeneity was assessed using
analyses ofvariance followed by multiple comparison tests.
RESULTS
Comparison of MVD in tumours and normal tissues
Blood vessels were heterogeneously distributed in the stroma of
the tumours as well as in the stroma adjacent to the bronchial
epithelium in normal lung tissue. Examples ofboth types oftissue
are shown in Figure 1. MVD was determined in 60 lung carci-
nomas and nine normal bronchus samples using two different
methods (h-MVD and a-MVD). A good correlation was found
between the two methods of quantitating MVD; Spearman rank
correlation showed that the rank ordering ofthe tissues by h-MVD
and a-MVD was similar (lung tumours, rho = 0.76, P < 0.001;
normal bronchus, rho = 0.95, P < 0.001).
Data presented in Table 2 show that h-MVD values were similar
in tumours and in normal tissues [t(67) = 0.1, P = 0.93]. In
contrast, a-MVD values were significantly higher in normal
bronchus than in tumours [t(67) = 2.9, P = 0.005].
There was considerable heterogeneity in MVD among speci-
mens within each type of tissue. For example, one factor analysis
of variance for a-MVD revealed significant differences among a
random sample often lung tumours [F(9,170) = 86, P <0.001] and
among the 9 normal bronchus samples [F(8,81) = 9.7, P < 0.001].
Analysis of microvascular heterogeneity within lung
tumours
MVD values in multiple blocks offour tumours
Forty-seven blocks obtained from four lung carcinomas (desig-
nated L1-L4) were analysed. Blocks had been taken from three
regions of the tumour: the periphery (region 1), the centre of the
tumour (region 3), and midway between the periphery and the
centre (region 2). One section from each block was stained for
vWF and scored for h-MVD and a-MVD. The values obtained are
shown in Figure 2, and the detransformed means ofthe square root
data for each region and tumour are shown in Table 3.
Variation between and within regions and tumours
One-factor analysis of variance showed that, for each tumour,
there were significant differences in MVD among multiple blocks
taken from the same region [P < 0.05 for 9 of 11 regions]. One
factor analyses of variance were also performed separately for
each tumour to assess differences in MVD between the regions
within a given tumour. For tumours L3 and L4, there were no
significant differences between regions but, for tumours LI and
L2, the microvascular density was greater towards the periphery of
the tumour, i.e. MVD in region 1 was greater than that in region 2,
which was, in turn, greater than that in region 3 [F(2,117) = 62,
P < 0.001, for tumour LI and F(2,417) = 166, P<0.001, for
tumour L2]. When the four tumours were considered together in
a two-factor analysis of variance, the a-MVD values revealed
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Table 3 Heterogeneity of microvascular density in lung tumours
Detransformed mean of square root data
For each region For each tumour
Tumour Regiona nb h-MVD a-MVD h-MVD a-MVD
Ll 1 2 210 115
2 2 155 75 146 69
3 2 87 30
L2 1 6 279 203
2 6 265 172 236 142
3 9 193 92
L3 1 6 215 121
2 3 237 129 223 121
3 6 222 117
L4 1 2 159 68
2 2 123 54 138 63
3 1 131 70
Average microvascular density (a-MVD) and highest microvascular density (h-MVD), both expressed as vessels mm-2, were determined for
multiple blocks from four lung tumours (L1-L4) as described in Materials and methods. aBlocks were taken from three regions of each tumour:
(1) the tumour periphery, (3) the centre of the tumour and (2) an area between regions 1 and 3. bn, Number of blocks taken from each region.
borderline significance between the three tumour regions, with
region 3 having lower values than regions 1 and 2 [F(2,6) = 4.3,
P = 0.07], but there were no significant differences between
h-MVD values in the three regions [F(2,6) = 3.3, P = 0.11].
Although there was considerable variation in the MVD of
blocks from within each tumour and within each region, the
variation between the four tumours was significantly greater
[F(3,936) = 84, P < 0.001]. This finding was also revealed
when the mean values of the two counting methods were
analysed [F(3,43) = 8.2, P < 0.001, for a-MVD and F(3,43) = 9.1,
P < 0.001, for h-MVD].
Comparison ofvascularity estimate using a single blockv
multiple blocks
Based on the overall vascularity values shown in Table 3, the four
tumours could be ranked in decreasing order as L2 > L3 > LI >
L4. However, post-ANOVA multiple comparison tests showed
that, although tumours L2 and L3 had significantly higher
microvascular density than tumours LI and L4 (P < 0.05), there
were no significant differences between tumours L2 and L3 and
between LI and L4. Consequently a two-tier ranking was defined
as the MVD for tumours L2 and L3 being greater than that of
tumours LI and L4.
Table 4 Frequency at which correct tumour vascularity ranking was
obtained for 50 random selections of one block per tumour
Vascularity measurement
Tumour ranking h-MVD (%) a-MVD (%)
Two-tier 68 74
Four-tier 6 16
Vascularity was assessed in 47 blocks from four tumours (5-21 blocks per
tumour) using two methods (h-MVD and a-MVD). The tumours were ranked
into either two or four tiers according to their overall vascularity. Results show
frequency (%) for the different rankings and vascularity measurements.
We then assessed whether determining the microvascular density
in a single block was sufficient to provide an estimate ofthe overall
microvascular density in agiven tumour. To thatend, randomblocks
from each tumour were chosen and the ranking oftheir microvessel
scores noted in ordertodetermine thefrequency atwhichthecorrect
ranking of the four tumours was obtained. The correct ranking was
defined as either two-tier [(L2 and L3) > (LI and L4)] or four-tier
(L2 > L3 > LI > [A). In 50 random selections, the correct ranking
was obtained in between 6% and 74% of cases, depending on the
measurement ofvascularity and the ranking system used (Table4).
DISCUSSION
Confidence in the value ofvascularity as a prognostic indicator in
human tumours has been undermined by the contradictory results
published (see Introduction). Vascularity may be quantitated by
various methods, but most studies have used the highest micro-
vascular density in the 'hot spot' or most vascularized area of a
section (h-MVD) since its introduction by Weidner et al (1991).
This method is biased by definition, as it relies on quantitating
only the most vascularized area of the section. Finding such an
area can be a source of significant inter- and intra-observer varia-
tion (Axelsson et al, 1995). However, the rationale for using this
method is based on the widely accepted hypotheses that (a) the hot
spot results from angiogenic activity in the area, probably after the
development of an angiogenic clone (Folkman, 1994), (b) the rate
limiting factor in metastasis is not the average but the highest
MVD (Horak et al,1992) and (c) using h-MVD avoids the problem
ofheterogeneity within the section (Bochner et al, 1995).
Heterogeneity in the MVD of a tumour may occur not only
within a section but also between different blocks ofa tumour, and
such heterogeneity may be the reason for the contradictory results
published to date (Van Hoefet al,1993; De Jong et al, 1995). With
these questions in mind, the aim of our study was to test the
hypotheses that (a) MVD represents angiogenesis in lung tumours
and (b) the measurement of MVD in a single block is representa-
tive ofthe MVD ofthe tumour.
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We estimated vascularity using two methods that represent the
highest (h-MVD) and the random average (a-MVD) microvascular
density. A strong correlation was found between the two methods,
suggesting that a putative association between MVD and clinical
or pathological parameters should be detected irrespective of the
method used to measure MVD. Previous studies have also shown a
good correlation between different methods used to assess vascu-
larity (Chandrachud et al, 1997), including subjective visual
appraisal (Fox et al, 1995).
Various studies have shown that vascularity is higher in tumours
than in the corresponding normal tissues. In oral lesions vascu-
larity increased significantly with disease progression from normal
oral mucosa, through increasing levels of dysplasia to early and
late carcinomas (Pazouki et al, 1997). In the lung, vascularity
measured in five selected areas of highest neovascularization by
automated image analysis was found to be increased in specimens
with dysplasia and carcinoma in situ by comparison to the normal
bronchial mucosa (Fisseler-Eckhoff et al, 1996). Although such
studies do not distinguish between angiogenic (tumour-induced)
and host tissue vessels, it is reasonable to attribute the elevated
tumour vascularity to angiogenesis. However, possible differences
in vascularity between tumours and normal tissues clearly depend
on the location and type of the tumour as well as the method used
to measure vascularity (Pazouki et al, 1997). The abundant
microvasculature of the lung may be incorporated into a growing
tumour and become part ofthe tumourblood supply (Kolin, 1995);
as a consequence, low tumour vascularity may result from rapid
tumour growth. Interestingly, we have recently reported that low a-
MVD in lung tumours is associated with poor prognosis (P = 0.06)
(Chandrachud et al, 1997).
In the present study, we found that h-MVD values in lung
tumours were not significantly higher than those observed in the
normal bronchus where the carcinomas originate. Moreover,
a-MVD values were significantly higher in the normal bronchus
than in the tumours (Table 3). These findings suggest that MVD
measured with pan-endothelial antibodies either in the 'hot spot'
(h-MVD) or throughout the section (a-MVD) does not necessarily
represent angiogenesis in lung tumours.
Heterogeneity in MVD among blocks taken from the same
tumour has been observed previously in a relatively small number
of blocks taken from a larger number of tumours (Revesz et al,
1989; Van Hoef et al, 1993; Axelsson et al,1995; De Jong et al,
1995). In the present study we examined both h-MVD and a-MVD
in 47 blocks taken from four lung tumours. We then assessed how
the estimated vascularity of the four tumours was affected when
vascularity was quantitated in a single block rather than multiple
blocks. To that end, the tumours were ranked into either two or
four tiers according to their overall vascularity and we determined
the frequency ofobtaining the correct ranking when a single block
per tumour was selected. This is a novel and effective way of
describing the accuracy (or inaccuracy) of a single block measure-
ment, given the available data. In 50 random selections, the correct
ranking was achieved in 68-74% of cases with the two-tier
ranking. From a biological point of view, the four tumours exam-
ined in this study should be divided into two categories, rather than
four. However, more than two categories might be expected in a
study involving a large series oftumours; therefore, the frequency
ofobtaining the correct ranking in such a study would be closer to
the 6-16% of cases that we obtained with the four-tier ranking. It
is also of interest that the highest MVD value was not necessarily
found in the periphery of the tumour, so that even if it were
possible to select blocks from this region, this would not guarantee
finding the highest MVD of the tumour. These results support the
view that discrepancies between results obtained in different
laboratories may be due to tumour heterogeneity.
When assessing the value of vascularity as a tumour prognostic
indicator, the problem presented by tumour heterogeneity will
remain whenever the tumour is large enough to be preserved in
multiple blocks, as is often the case with lung carcinomas. The
value of MVD as an index of angiogenesis and as a prognostic
factor may depend, therefore, on the type and size of the tumours
examined. It may be useful for carcinomas in-situ or for tumours
that are relatively small, so that a single block will be representa-
tive of the tumour and sections will include the excision margins
(Pazouki et al, 1997). For larger tumours, vascularity measured by
MVD using pan-endothelial antibodies does not appear to be a
reliable index of angiogenesis and is not likely to be useful as a
routine assay using current methods.
Nevertheless, we found that intertumour variation in MVD
values was statistically significant in spite of significant intra-
tumour variation. Heterogeneity of any tumour parameter must be
greater between tumours than within tumours for that parameter to
be ofclinical value. As this is the case for MVD, it is possible that
this parameter may become informative when combined with
other indices of angiogenesis and/or other methods to measure
vascularity.
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